CAMX:STO
Camurus AB
၆၇၇.၀၀ SEK
arrow_upward
+၁.၀၄%(+၇.၀၀) 1D
အောက် ၂၉, GMT+၁ ၁၅:၃၈:၅၃ · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CAMX...
Open
၆၆၉.၅၀ SEK
High
၆၈၂.၀၀ SEK
Low
၆၆၃.၀၀ SEK
Mkt. cap
ဋေ ၄.၀၆ ထ
Avg. vol.
၉.၁၄ သောင်း
Volume
၅.၃၅ သောင်း
52-wk high
၇၁၀.၀၀ SEK
52-wk low
၄၃၀.၈၀ SEK
Shares outstanding
၆.၀၆ ကုဋေ
No. of employees
၃၁၆
Open
၆၆၉.၅၀ SEK
High
၆၈၂.၀၀ SEK
Low
၆၆၃.၀၀ SEK
Mkt. cap
ဋေ ၄.၀၆ ထ
Avg. vol.
၉.၁၄ သောင်း
Volume
၅.၃၅ သောင်း
52-wk high
၇၁၀.၀၀ SEK
52-wk low
၄၃၀.၈၀ SEK
Shares outstanding
၆.၀၆ ကုဋေ
No. of employees
၃၁၆
News stories
From web sources and news partners
CNBC
·
ပြီးခဲ့သည့် ၁၅ မိနစ်
The AI trade is hitting some bumps in the road. Why the bull case for stocks remains
BigGo Finance
·
ပြီးခဲ့သည့် ၃၄ မိနစ်
Dow Retreats as PCE Inflation Hits 3.6%, Alphabet Slump Offsets Microsoft Strength
Crypto News
·
ပြီးခဲ့သည့် ၃၆ မိနစ်
NYSE owner ICE partners with trade[XYZ] for US perpetual futures
TradingView
·
ပြီးခဲ့သည့် ၃ နာရီ
Saia (NASDAQ:SAIA) posts better-than-expected sales in Q3 2026
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB